prostaglandin e2
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
2
Earliest trial started Mar 31, 2021 (NCT04743297)
Timeline
No events for the selected filters.
Indications
Approved for
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT07261332 | N/A | May 10, 2025 | University of Health Sciences Lahore |
| NCT04780269 | Phase 4 | Oct 31, 2021 | Guangzhou Medical University |
| NCT04743297 | Phase 4 | Mar 31, 2021 | University of Maribor |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Guangzhou Medical University | Academic/Hospital | 1 | 1 | 1 | 2021 |
| University of Health Sciences Lahore | Academic/Hospital | 1 | 1 | 1 | 2025 |
| University of Maribor | Academic/Hospital | 1 | 1 | 1 | 2021 |
3 organizations
Page 1 / 1